| Breast Cancer |
1 |
1 |
| Advanced and Metastatic Breast Cancer |
0 |
0.88 |
| Cancer |
0 |
0.7 |
| Breast |
0 |
0.59 |
| Dentistry and Oral Health |
0 |
0.57 |
| Endocrine Therapy |
0 |
0.22 |
| Tumor |
0 |
0.18 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.15 |
| HIV Infection |
0 |
0.15 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.15 |
| Aromatase Inhibitors |
0 |
0.13 |
| Aminotransferase |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Thrombocytopenia |
0 |
0.06 |
| Adjuvant Therapy |
0 |
0.04 |
| Alopecia |
0 |
0.04 |
| Anemia |
0 |
0.04 |
| California |
0 |
0.04 |
| Chemotherapy |
0 |
0.04 |
| Diarrhea |
0 |
0.04 |
| Dizziness |
0 |
0.04 |
| Dorsum |
0 |
0.04 |
| Drug Development |
0 |
0.04 |
| Fatigue |
0 |
0.04 |
| Headache |
0 |
0.04 |
| Leukopenia |
0 |
0.04 |
| Lymph Node |
0 |
0.04 |
| Medical Oncology |
0 |
0.04 |
| Nausea |
0 |
0.04 |
| Neoadjuvant Therapy |
0 |
0.04 |
| Neutropenia |
0 |
0.04 |
| NHS |
0 |
0.04 |
| Radiation Therapy |
0 |
0.04 |
| Selective Estrogen Receptor Modulators |
0 |
0.04 |
| Stomatitis |
0 |
0.04 |
| Surgery |
0 |
0.04 |